Medroxyprogesterone acetate-driven increase in breast cancer risk might be mediated via cross-talk with growth factors in the presence of progesterone receptor membrane component-1-Reference-Cited by-同舟云学术

Medroxyprogesterone acetate-driven increase in breast cancer risk might be mediated via cross-talk with growth factors in the presence of progesterone receptor membrane component-1

Published:2013-10 Issue:2 Volume:76 Page:129-133
ISSN:0378-5122
Container-title:Maturitas
language:en
Short-container-title:Maturitas

Author:

Zhou Jing,Yu Qi,Chen Rong,Seeger Harald,Fehm Tanja,Cahill Michael A.,Mueck Alfred O.,Neubauer Hans

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,General Biochemistry, Genetics and Molecular Biology

Reference31 articles.

1. Risks and benefits of estrogen plus progestin in healthy postmenopausal women;Writing Group for the Women's Health Initiative Investigators;JAMA,2002

2. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy;The Women's Health Initiative Steering Committee;JAMA,2004

3. Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study;Fournier;Breast Cancer Research and Treatment,2008

4. The presence of a membrane-bound progesterone receptor sensitizes the estradiol-induced effect on the proliferation of human breast cancer cells;Neubauer;Menopause,2011

5. Progestins and membrane-initiated effects on the proliferation of human breast cancer cells;Ruan;Climacteric,2012

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The WHO claims estrogens are ‘carcinogenic’: is this true?;Climacteric;2023-04-17

2. Effects of Hormones on Breast Development and Breast Cancer Risk in Transgender Women;Cancers;2022-12-30

3. Clinical importance of PGRMC1 in hormone responsive breast cancer;Breast Care;2022-11-08

4. Crosstalk between progesterone receptor membrane component 1 and estrogen receptor α promotes breast cancer cell proliferation;Laboratory Investigation;2021-04-26

5. Association of circulating Progesterone Receptor Membrane Component-1 (PGRMC1) with PGRMC1 expression in breast tumour tissue and with clinical breast tumour characteristics;Maturitas;2020-10